Skip to content

Meet us at COP31Read more

Optimi Health Corp Sustainability Reports

The company operates as a vertically integrated pharmaceutical drug manufacturer licensed by Health Canada for the production of controlled substances. It specializes in producing botanical psilocybin and MDMA formulations for clinical research and therapeutic use.

Sector: Manufacturing

Country: Canada

Exchange: Canadian Securities Exchange

LEI: 98450063FDFF8UD3Q652

4 reports from 2021 to 2025